← SynDRA
ALFUZOSIN
SynDRA canonical compound SYN0001525 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRA1A |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | benign prostatic hyperplasia (BPH) |
|---|
| Disease area | urology |
|---|
All known targets
- ADRA1A
- ADRA1D
- ADRA1B
- ACHE
- Adra1d
- SCN10A
- SCN11A
- SCN1A
- SCN2A
- SCN3A
- SCN4A
- SCN5A
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRA1A AGONIST
- Adrenergic receptor alpha-1 agonist
- ADRA1D AGONIST
- ADRA1B AGONIST
- ADRA1A ANTAGONIST
- ADRA1B ANTAGONIST
- ADRA1D ANTAGONIST
Drug classes
- Adrenergic alpha-Antagonists
- alpha-Adrenergic Blocker
- Adrenergic Agents
- Adrenergic alpha-1 Receptor Antagonists
- Adrenergic Antagonists
- Neurotransmitter Agents
- Urological Agents
ATC classes
- G04C · DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Cross-references
Synonyms
- alfuzosin hydrochloride
- xatral
- SL 77
- alfuzosin HCl
- Alfuzosine
- Alfuzosina
- NSC-760065
- Alfusosine
- Alfuzosinum
- Alphuzosine
- Alfuzosina [Spanish]
- Alfuzosine [French]
- Alfuzosinum [Latin]
- Alfuzosin (INN)
- Alfuzosin [INN:BAN]
- Xatral (TN)
- N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide
- N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide
- N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide
- Xatral
- Alfetim
- Alfoten
- Urion
- Uroxatral
- Alfuzosin HCl
- Alfuzosin Hydrochloride
- Alfuzosin hydrochloride [USAN]
- Xatral OD
- Xatral Retard
- Xatral SR
- Xatral XL
- SL 77 499-10
- SL-77499-10
- SL-7749910
- Uroxatral, Alfuzosin hydrochloride
- Alfuzosin hydrochloride (JAN/USAN)
- SL-77.0499-10
- N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride
Look up ALFUZOSIN in the interactive SynDRA portal →